|
|
||||||||
Journal of Applied Physiology, Vol 73, Issue 6 2470-2475, Copyright © 1992 by American Physiological Society
ARTICLES |
M. C. Hogan, D. C. Willford, P. E. Keipert, N. S. Faithfull and P. D. Wagner
Department of Medicine, University of California, San Diego, La Jolla 92093-0623.
A perfluorocarbon emulsion [formulation containing 90% wt/vol perflubron (perfluorooctylbromide); Alliance Pharmaceutical] was used to increase O2 solubility in the plasma compartment during hyperoxic low hemoglobin concentration ([Hb]) perfusion of a maximally working dog muscle in situ. Our hypothesis was that the increased plasma O2 solubility would increase the muscle O2 diffusing capacity (DO2) by augmenting the capillary surface area in contact with high [O2]. Oxygen uptake (VO2) was measured in isolated in situ canine gastrocnemius (n = 4) while working for 6 min at a maximal stimulation rate of 1 Hz (isometric tetanic contractions) on three to four separate occasions for each muscle. On each occasion, the last 4 min of the 6-min work period was split into 2 min of a control treatment (only emulsifying agent mixed into blood) and 2 min of perflubron treatment (6 g/kg body wt), reversing the order for each subsequent work bout. Before contractions, the [Hb] of the dog was decreased to 8-9 g/100 ml and arterial PO2 was increased to 500-600 Torr by having the dog breathe 100% O2 to maximize the effect of the perflubron. Muscle blood flow was held constant between the two experimental conditions. Plasma O2 solubility was almost doubled to 0.005 ml O2 x 100 ml blood-1 x Torr-1 by the addition of the perflubron. Muscle O2 delivery and maximal VO2 were significantly improved (at the same blood flow and [Hb]) by 11 and 12.6%, respectively (P < 0.05), during the perflubron treatment compared with the control. O2 extraction by the muscle remained the same between the two treatments, as did the estimate of DO2.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
N. Lai, G. M. Saidel, B. Grassi, L. B. Gladden, and M. E. Cabrera Model of oxygen transport and metabolism predicts effect of hyperoxia on canine muscle oxygen uptake dynamics J Appl Physiol, October 1, 2007; 103(4): 1366 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P Wilkerson, J. Rittweger, N. J. A Berger, P. F Naish, and A. M Jones Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans J. Physiol., October 15, 2005; 568(2): 639 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Eggleton, T. K. Roy, and A. S. Popel Predictions of capillary oxygen transport in the presence of fluorocarbon additives Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2250 - H2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Ameredes, W. F. Brechue, and W. N. Stainsby Mechanical and metabolic determination of VO2 and fatigue during repetitive isometric contractions in situ J Appl Physiol, June 1, 1998; 84(6): 1909 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marchbank Fluorocarbon emulsions Perfusion, March 1, 1995; 10(2): 67 - 88. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |